U.S. Capital Markets Stock News

Q2 Holdings recently reported that competitive pressures and weaker-than-hoped annual recurring revenue growth are weighing on its digital banking platform business, alongside relatively low gross margins versus peers. At the same time, the company’s Q3 2025 results showed revenue growth of about 15% year over year and a swing to US$15.00 million in net income, supported by a US$150.00 million share repurchase plan and leadership changes focused on its AI roadmap. We’ll now examine how...

NetApp, Inc. recently reported fiscal third-quarter 2026 results showing higher revenue of US$1.713 billion and net income of US$334 million year on year, while also declaring a quarterly dividend of US$0.52 per share payable on April 22, 2026. The company paired these results with guidance calling for fourth-quarter 2026 revenue of US$1.795 billion–US$1.945 billion and earnings per share of US$1.76–US$1.86, highlighting momentum in all-flash storage and its Keystone Storage-as-a-Service...

Skyward Specialty Insurance Group (SKWD) is back in focus after reporting fourth quarter and full year 2025 results that show higher revenue and net income, along with contributions from the recently integrated Apollo acquisition. See our latest analysis for Skyward Specialty Insurance Group. The strong fourth quarter and Apollo integration have arrived alongside a 1 month share price return of 4.15% and a year to date share price decline of 4.42%. The 3 year total shareholder return of...

Baldwin Insurance Group (BWIN) has attracted fresh attention after recent trading left the stock around $23.23, with mixed total returns across the past year, month and past three months. See our latest analysis for Baldwin Insurance Group. The latest 1 day share price return of 25.6% and 7 day share price return of 40.5% contrast with a 1 year total shareholder return decline of 43.5%, suggesting short-term momentum is picking up after a tougher period for long-term holders. If this sharp...

Why Enpro's latest earnings and acquisition plans matter for investors Enpro (NPO) has just combined a mixed fourth quarter, with a net loss alongside higher sales, with new 2026 revenue guidance and fresh comments about pursuing acquisitions to support its Enpro 3.0 strategy. See our latest analysis for Enpro. Despite the recent quarterly net loss and news on 2026 revenue guidance and acquisition plans, Enpro’s share price has moved up in recent months, with a 30 day share price return of...

Simmons First National Corporation recently announced that its board approved a quarterly cash dividend of US$0.215 per Class A share, payable on April 1, 2026 to shareholders of record as of March 13, 2026, and separately authorized a share repurchase program of up to US$175,000,000 through January 31, 2028. Together, the 1% year-on-year dividend increase and sizable multi-year buyback authorization highlight management’s focus on returning capital to shareholders while maintaining balance...

Why UMH Properties (UMH) Is On Investors’ Radar Today UMH Properties (UMH) has been drawing attention after a mixed stretch in its share performance, with a 1 day return of negative 4.19% and a 1 year total return of negative 15.71%. For investors tracking real estate investment trusts, those numbers sit alongside a past 3 months total return of 1.07% and a 3 year total return of 6.84%, prompting a closer look at what you are actually paying for today. See our latest analysis for UMH...

Silgan Holdings Inc. previously announced that its Board approved a US$0.21 per share quarterly dividend, payable on March 31, 2026 to shareholders of record on March 17, 2026, representing a 5% increase and extending a streak of 88 consecutive quarterly payments since 2004. This 22-year record of annual dividend increases highlights Silgan’s consistent cash generation and its emphasis on returning capital to shareholders alongside ongoing operational initiatives. We’ll now explore how this...

If you are wondering whether Etsy at around US$54.88 is a bargain or a value trap, this article will help you make sense of what the current share price might be implying. The stock has recently moved, with a 5.2% return over the last 7 days and 3.6% over the last 30 days, while year to date it is at a 4.2% decline and the 3 year and 5 year returns stand at 54.8% and 72.6% declines, with a 7.2% return over the last year. Recent headlines have focused on Etsy’s position as an online...

In late February 2026, Atlanta Braves Holdings, Inc. reported fourth-quarter 2025 revenue of US$61.3 million and a net loss of US$41.45 million, alongside full-year 2025 revenue of US$732.49 million and a net loss of US$23.37 million. A day earlier, the company unveiled BravesVision, an in-house multimedia platform that will become the official local television home of the Braves from the 2026 season, giving the organization full control over production, distribution, and monetization of...

InterDigital (IDCC) has attracted fresh attention after unveiling a world first collaborative cellular and Wi-Fi sensing trial with Türk Telekom using preliminary 6G architecture, alongside a broad Sony patent deal and new AI and video showcases. See our latest analysis for InterDigital. Those 6G, AI and patent headlines have arrived after a strong run, with a 12.3% year to date share price return and a very large 5 year total shareholder return. This suggests recent news is feeding into an...

In late February 2026, Butterfly Network, Inc. reported Q4 2025 results showing US$31.51 million in revenue versus US$22.35 million a year earlier, narrower quarterly losses, and issued 2026 revenue guidance of US$117 million to US$121 million alongside a new US$57.00 million shelf registration for ESOP-related Class A shares. The company’s first quarter of positive operating cash flow, boosted by its Midjourney partnership and Compass AI launch, highlights a shift toward higher-margin,...

Why Halozyme Therapeutics Is On Investors’ Radar Today Halozyme Therapeutics (HALO) is drawing attention as investors weigh its recent share performance, including a modest 1 day gain and mixed short term returns, in relation to its current valuation and underlying biopharmaceutical licensing business. See our latest analysis for Halozyme Therapeutics. At the current share price of US$69.53, Halozyme Therapeutics has seen short term share price pressure with a 7 day return of 2.04% and 30 day...

Invitation Homes (INVH) has come into focus after issuing 2026 guidance for same store core revenue growth of 1.3% to 2.5%, together with detailed fourth quarter and full year 2025 results. See our latest analysis for Invitation Homes. At a share price of US$26.34, Invitation Homes has seen a 4.11% 7 day share price return but a weaker 1 year total shareholder return of 19.53% decline, suggesting recent momentum is improving after a softer stretch. If this single name feels interest rate...

If you are trying to work out whether Roku at around US$98.41 is priced for opportunity or disappointment, starting with a clear view of its current valuation is essential. The stock has had a mixed run, with a 10.5% return over the last 7 days and 3.4% over the last 30 days, set against a 9.5% year to date decline and longer term returns of 17.8% over 1 year, 50.0% over 3 years, and a 72.2% decline over 5 years. Recent headlines have continued to focus on Roku's position in streaming...

Associated Banc-Corp (ASB) has drawn investor attention after recent share price moves, with the stock showing mixed returns over the past week, month, and past 3 months, while longer term performance remains positive. See our latest analysis for Associated Banc-Corp. Recent trading has cooled, with a 1-day share price decline of 5.95% and a 7-day share price decline of 7.53%. However, the 1-year total shareholder return of 10.28% and 5-year total shareholder return of 48.16% indicate that...

Simply Good Foods recently brought founder Joe Scalzo back as CEO on January 19, 2026, alongside a 2 million stock option grant and a US$199,000 share purchase by the CFO, signaling renewed leadership commitment. This leadership return and insider buying sparked a sharp rise in retail investor interest on Reddit, highlighting how management alignment can influence market sentiment for a consumer nutrition company positioned at the intersection of fitness, wellness, and everyday eating. With...

Wondering whether Robinhood Markets at around US$75.85 still offers fair value or has run ahead of itself? This article walks through what the numbers are really saying about the stock. The share price is roughly flat over the last week with a 0.3% decline, after a sharper 25.1% decline over 30 days that comes on the back of a 51.4% return over the past year and a very large gain of about 7x over three years. Recent headlines have focused on Robinhood's role in retail trading, its zero...

Progyny’s recent share moves in focus Progyny (PGNY) has been under pressure, with the stock showing negative returns over the past month, past 3 months and year. This has prompted investors to reassess how its current valuation lines up with its underlying business. See our latest analysis for Progyny. The sharp 1 day share price decline of 20.49% to US$17.69 adds to already weak momentum, with the 1 year total shareholder return of 21.48% and 3 year total shareholder return of 51.15% both...

If you are trying to figure out whether Freshpet at around US$84.45 is a bargain or already pricing in a lot of optimism, you are asking the right question for this stock. The share price performance has been mixed, with a 13.3% return over the last 7 days, 21.2% over 30 days, 40.4% year to date, but a 21.1% decline over 1 year and a 39.4% decline over 5 years. These swings mean recent news and expectations have become a big part of the story, as investors reassess what they are willing to...

Upcoming earnings put Astrana Health in focus Astrana Health (ASTH) is back on investors’ radar ahead of its March 2, 2026 quarterly earnings report, with attention on whether results and guidance align with the company’s recent revenue and earnings profile. See our latest analysis for Astrana Health. At a share price of US$20.33, Astrana Health has seen recent momentum soften, with a 30 day share price return of 10.6% decline and a 1 year total shareholder return of 19.9% loss, even as its...

CIBC and BMO Capital have both highlighted Brookfield Business Partners (NYSE:BBU) with fresh Outperform ratings, drawing attention to its track record, ties to the broader Brookfield group, and current valuation. See our latest analysis for Brookfield Business Partners. At around US$34.08, Brookfield Business Partners has seen short term share price pressure, with a 1-day share price return of 1.70% decline and a year to date share price return of 4.88% decline. However, its 1-year total...

United Rentals (NYSE:URI) and Procore Technologies launched a new telematics integration that brings rental equipment data directly into Procore's Resource Management solution. The collaboration connects jobsite equipment usage and location data with project planning tools to support more precise resource allocation. The integration is designed to help contractors address equipment inefficiencies and improve coordination across construction projects. For you as an investor, this move sits...

In February 2026, CRH plc reported fourth‑quarter 2025 revenue of US$9,416 million and net income of US$1,025 million, delivering record full‑year 2025 results with revenue of US$37,447 million and net income of US$3,753 million, alongside a 5% increase in its quarterly dividend to US$0.39 per share and continued share buybacks. CRH also issued 2026 guidance for net income of US$3.90–US$4.10 billion and diluted EPS of US$5.60–US$6.05, which, together with sustained margin expansion, higher...